# Evaluation of Pharmacokinetics and Safety of AJU-A51 in Healthy Adults

> **NCT04972539** · PHASE1 · COMPLETED · sponsor: **AJU Pharm Co., Ltd.** · enrollment: 48 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** AJU-A51 Tab.
- **DRUG:** A51R1 Tab. and A51R2 Tab.

## Key facts

- **NCT ID:** NCT04972539
- **Lead sponsor:** AJU Pharm Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-01
- **Primary completion:** 2020-11-30
- **Final completion:** 2021-03-09
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2021-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04972539

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04972539, "Evaluation of Pharmacokinetics and Safety of AJU-A51 in Healthy Adults". Retrieved via MORVS 2026-09-29 from https://api.morvs.ai/clinical/NCT04972539. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*